Xiaofan Ding

Sar, 999078, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Crosstalk Between Cis-Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.

Crosstalk Between Cis-Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.

Journal: Cancers
Published: February 04, 2026

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma.

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2025

Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment.

Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 08, 2024

The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy.

The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy.

Journal: International journal of biological sciences
Published: October 08, 2024

A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression.

A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression.

Journal: Cancer research
Published: July 10, 2024

PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex.

PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex.

Journal: International journal of biological sciences
Published: March 11, 2024

CHHM: a Manually Curated Catalogue of Human Histone Modifications Revealing Hotspot Regions and Unique Distribution Patterns.

CHHM: a Manually Curated Catalogue of Human Histone Modifications Revealing Hotspot Regions and Unique Distribution Patterns.

Journal: International journal of biological sciences
Published: March 05, 2024

Corrigendum to "Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity" [Cancer Lett., 548, (1 November 2022)].

Corrigendum to "Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity" [Cancer Lett., 548, (1 November 2022)].

Journal: Cancer letters
Published: December 31, 2023

Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.

Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.

Journal: BMC cancer
Published: September 21, 2023

m6 A-Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis.

m6 A-Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 17, 2022

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.

Journal: Hepatology (Baltimore, Md.)
Published: June 02, 2022

Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity.

Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity.

Journal: Cancer letters
Published: January 17, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026